Please log in to view this page
Username
Password
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
